(Q36109852)

12 August 2017

1 reference

title

Liver disease after renal transplantation (English)

1 reference

12 August 2017

K. V. Rao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1585941

11 October 2022

W. R. Anderson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1585941

11 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1585941

11 October 2022

publication date

1 May 1992

1 reference

American Journal of Kidney Diseases

12 August 2017

published in

1 reference

12 August 2017

volume

19

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

496-501

1 reference

Renal transplantation for the nephrologist: why we need transplantation medicine

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Jaundice after Renal Allotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Etiology of Liver Disease in Renal-Transplant Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Late mortality and morbidity in recipients of long-term renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Successful acyclovir therapy of severe varicella hepatitis in an adult renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Cyclosporin A hepatotoxicity in 66 renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Methyldopa liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Hepatic Dysfunction During Isoniazid Chemoprophylaxis in Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Hemosiderosis: an unrecognized complication in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Is renal transplantation involved in post-transplantation liver disease? A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

The clinical and pathological course of hepatitis B liver disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Hepatitis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

The impact of renal transplantation on the course of hepatitis B liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Chronic hepatitis in kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Hemosiderosis and hemochromatosis in renal transplant recipients. Clinical and pathological features, diagnostic correlations, predisposing factors, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Cell-mediated immunity in acute and chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Prognostic significance of hepatitis B antigenemia in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

Transmission of hepatitis C virus by organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980962-0

7 January 2021

10.1016/S0272-6386(12)80962-0

Identifiers

DOI

1 reference

12 August 2017

1 reference